- DGIST Professor Park Chiyoung and Inha University Professor U-hyeok Choi collaborate to develop sustainable, flexible electrode sensor material - Research results published in the Chemical Engineering Journal

- DGIST, KAIST, and Korea University collaborated to develop a three-dimensional device with reversible heating/cooling based on the thermal radiation phenomenon - Research published as a cover article in Advanced Materials

Researchers have shown that they can accurately re-create clinical trials of new treatments using ‘digital twins’ of real cancer patients. The technology, called FarrSight®-Twin, which is based on algorithms used by astrophysicists to discover black holes, will be presented at the 36th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics in Barcelona, Spain. The researchers say that this approach could be used by cancer researchers to run virtual clinical trials before testing new treatments on patients. It could also be used alongside clinical trials with a digital twin for each patient taking part, which together could form a control group for any trial. Ultimately, it might mean that patients could have different treatments tested on their digital twin to help select the most suitable treatment ahead of time.